BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 15897582)

  • 1. Recombinant Sendai virus vector induces complete remission of established brain tumors through efficient interleukin-2 gene transfer in vaccinated rats.
    Iwadate Y; Inoue M; Saegusa T; Tokusumi Y; Kinoh H; Hasegawa M; Tagawa M; Yamaura A; Shimada H
    Clin Cancer Res; 2005 May; 11(10):3821-7. PubMed ID: 15897582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of immunity in peripheral tissues combined with intracerebral transplantation of interleukin-2-producing cells eliminates established brain tumors.
    Iwadate Y; Yamaura A; Sato Y; Sakiyama S; Tagawa M
    Cancer Res; 2001 Dec; 61(24):8769-74. PubMed ID: 11751397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Sendai virus vectors deleted in both the matrix and the fusion genes: efficient gene transfer with preferable properties.
    Inoue M; Tokusumi Y; Ban H; Shirakura M; Kanaya T; Yoshizaki M; Hironaka T; Nagai Y; Iida A; Hasegawa M
    J Gene Med; 2004 Oct; 6(10):1069-81. PubMed ID: 15386740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.
    Iwadate Y; Yamaura A; Sakiyama S; Sato Y; Tagawa M
    Int J Oncol; 2003 Aug; 23(2):483-8. PubMed ID: 12851699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naked Sendai virus vector lacking all of the envelope-related genes: reduced cytopathogenicity and immunogenicity.
    Yoshizaki M; Hironaka T; Iwasaki H; Ban H; Tokusumi Y; Iida A; Nagai Y; Hasegawa M; Inoue M
    J Gene Med; 2006 Sep; 8(9):1151-9. PubMed ID: 16841365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-transmissible Sendai virus encoding granulocyte macrophage colony-stimulating factor is a novel and potent vector system for producing autologous tumor vaccines.
    Inoue H; Iga M; Nabeta H; Yokoo T; Suehiro Y; Okano S; Inoue M; Kinoh H; Katagiri T; Takayama K; Yonemitsu Y; Hasegawa M; Nakamura Y; Nakanishi Y; Tani K
    Cancer Sci; 2008 Nov; 99(11):2315-26. PubMed ID: 18957055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A defective nontransmissible recombinant Sendai virus mediates efficient gene transfer to airway epithelium in vivo.
    Ferrari S; Griesenbach U; Shiraki-Iida T; Shu T; Hironaka T; Hou X; Williams J; Zhu J; Jeffery PK; Geddes DM; Hasegawa M; Alton EW
    Gene Ther; 2004 Nov; 11(22):1659-64. PubMed ID: 15284837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological responsiveness to interleukin-2-producing brain tumors can be restored by concurrent subcutaneous transplantation of the same tumors.
    Iwadate Y; Tagawa M; Namba H; Oga M; Kawamura K; Tasaki K; Sakiyama S; Yamaura A
    Cancer Gene Ther; 2000 Sep; 7(9):1263-9. PubMed ID: 11023199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RG-2 glioma growth attenuation and severe brain edema caused by local production of interleukin-2 and interferon-gamma.
    Tjuvajev J; Gansbacher B; Desai R; Beattie B; Kaplitt M; Matei C; Koutcher J; Gilboa E; Blasberg R
    Cancer Res; 1995 May; 55(9):1902-10. PubMed ID: 7728757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen-specific T-cell induction by vaccination with a recombinant Sendai virus vector even in the presence of vector-specific neutralizing antibodies in rhesus macaques.
    Moriya C; Horiba S; Inoue M; Iida A; Hara H; Shu T; Hasegawa M; Matano T
    Biochem Biophys Res Commun; 2008 Jul; 371(4):850-4. PubMed ID: 18466766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sendai virus for gene therapy and vaccination.
    Griesenbach U; Inoue M; Hasegawa M; Alton EW
    Curr Opin Mol Ther; 2005 Aug; 7(4):346-52. PubMed ID: 16121700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sendai virus vectors as an emerging negative-strand RNA viral vector system.
    Bitzer M; Armeanu S; Lauer UM; Neubert WJ
    J Gene Med; 2003 Jul; 5(7):543-53. PubMed ID: 12825193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newly-developed Sendai virus vector for retinal gene transfer: reduction of innate immune response via deletion of all envelope-related genes.
    Murakami Y; Ikeda Y; Yonemitsu Y; Tanaka S; Kondo H; Okano S; Kohno R; Miyazaki M; Inoue M; Hasegawa M; Ishibashi T; Sueishi K
    J Gene Med; 2008 Feb; 10(2):165-76. PubMed ID: 18074401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraarterial delivery of genetic vectors for the treatment of malignant brain tumors.
    Cohen ZR; Duvdevani R; Nass D; Hadani M; Ram Z
    Isr Med Assoc J; 2001 Feb; 3(2):117-20. PubMed ID: 11344821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gene transduction for experimental brain tumors using recombinant adenovirus vector].
    Ichikawa T; Tamiya T; Adachi Y; Ono Y; Matsumoto K; Furuta T; Ohmoto T; Yoshida Y; Hamada H
    No To Shinkei; 1998 Aug; 50(8):731-8. PubMed ID: 9757466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Airway-directed gene transfer of interleukin-10 using recombinant Sendai virus effectively prevents post-transplant fibrous airway obliteration in mice.
    Shoji F; Yonemitsu Y; Okano S; Yoshino I; Nakagawa K; Nakashima Y; Hasegawa M; Sugimachi K; Sueishi K
    Gene Ther; 2003 Feb; 10(3):213-8. PubMed ID: 12571628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eradication of rat malignant gliomas by retroviral-mediated, in vivo delivery of the interleukin 4 gene.
    Benedetti S; Bruzzone MG; Pollo B; DiMeco F; Magrassi L; Pirola B; Cirenei N; Colombo MP; Finocchiaro G
    Cancer Res; 1999 Feb; 59(3):645-52. PubMed ID: 9973213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumors.
    Ram Z; Walbridge S; Heiss JD; Culver KW; Blaese RM; Oldfield EH
    J Neurosurg; 1994 Mar; 80(3):535-40. PubMed ID: 8113867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-12-mediated induction of systemic immunity in the periphery and recruitment of activated T cells into the brain produce limited antitumor effects compared with interleukin-2.
    Iwadate Y; Namba H; Sakiyama S; Yamaura A; Tagawa M
    Int J Mol Med; 2002 Dec; 10(6):741-7. PubMed ID: 12430001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.